UNSPSC 51294402: Adatanserin

This classification denotes a serotonin antagonist with the molecular formula C21H31N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5U6WQM26H, chemically known as tricyclo(3.3.1.1(3,7))decane-1-carboxamide, n-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)- but generally known as adatanserin, which bears US NIH Compound Identifier 130918. Adatanserin comes in base and hydrochloride form. European Medicines Agency schedules Adatanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05263MIG.

UNSPSC 51294402 Adatanserin is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity on record shows a mismatch between the code's nominal pharmaceutical scope and the actual work being solicited — Seminole County, Florida posted an IFB for Naloxone and Safe Drug Deactivation Systems, neither of which aligns with Adatanserin, a serotonin antagonist pharmaceutical. The code does not appear to reflect active state and local demand for Adatanserin itself. Procurement under this code, if any occurs, would typically target public health agencies, county health departments, or hospital systems acquiring pharmaceutical inventory through competitive bidding or cooperative purchasing vehicles, though current activity does not support that characterization.

The single recent opportunity originated from Seminole County, Florida, with an IFB (IFB60459723LAS) posted June 30, 2026, and due July 26, 2023, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The mismatch between the Adatanserin code designation and the Naloxone/deactivation-system procurement suggests either a tagging error or obsolete coding in the state and local procurement system. No additional recent opportunities under this code are evident in the available record. Business development professionals should verify current demand signals outside this code before committing resources; the present activity offers no reliable market signal for Adatanserin procurement at the state and local level.